NCT07152236View on ClinicalTrials.gov

Clinical Study on the Safety and Efficacy of B7H3 CAR T Cells in Patients With B7H3 Positive Solid Tumors

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

August 31, 2028

Study Completion Date

August 31, 2028

Conditions

Solid Tumors

Interventions

BIOLOGICAL

CAR-T

Eligible subjects who successfully passed screening will receive CAR-T cell infusion on Day 0 after lymphodepleting preconditioning chemotherapy.

Trial Locations (1)

523125

RECRUITING

Dongguan Taixin Hospital, Dongguan

All Listed Sponsors

lead

Guangzhou Bio-gene Technology Co., Ltd

INDUSTRY

NCT07152236 - Clinical Study on the Safety and Efficacy of B7H3 CAR T Cells in Patients With B7H3 Positive Solid Tumors | Biotech Hunter | Biotech Hunter